114 related articles for article (PubMed ID: 11922613)
21. Correlation of in vitro and in vivo models for the oral absorption of peptide drugs.
Föger F; Kopf A; Loretz B; Albrecht K; Bernkop-Schnürch A
Amino Acids; 2008 Jun; 35(1):233-41. PubMed ID: 17726639
[TBL] [Abstract][Full Text] [Related]
22. Co-treatment with grapefruit juice inhibits while chronic administration activates intestinal P-glycoprotein-mediated drug efflux.
Panchagnula R; Bansal T; Varma MV; Kaul CL
Pharmazie; 2005 Dec; 60(12):922-7. PubMed ID: 16398269
[TBL] [Abstract][Full Text] [Related]
23. Absorption study of deoxycholic acid-heparin conjugate as a new form of oral anti-coagulant.
Kim SK; Lee DY; Lee E; Lee YK; Kim CY; Moon HT; Byun Y
J Control Release; 2007 Jul; 120(1-2):4-10. PubMed ID: 17490773
[TBL] [Abstract][Full Text] [Related]
24. Preclinical pharmacokinetics and metabolism of 6-(4-(2,5-difluorophenyl)oxazol-5-yl)-3-isopropyl-[1,2,4]-triazolo[4,3-a]pyridine, a novel and selective p38alpha inhibitor: identification of an active metabolite in preclinical species and human liver microsomes.
Kalgutkar AS; Hatch HL; Kosea F; Nguyen HT; Choo EF; McClure KF; Taylor TJ; Henne KR; Kuperman AV; Dombroski MA; Letavic MA
Biopharm Drug Dispos; 2006 Nov; 27(8):371-86. PubMed ID: 16944451
[TBL] [Abstract][Full Text] [Related]
25. Rat jejunal permeability and metabolism of mu-selective tetrapeptides in gastrointestinal fluids from humans and rats.
Krondahl E; Orzechowski A; Ekström G; Lennernäs H
Pharm Res; 1997 Dec; 14(12):1780-5. PubMed ID: 9453068
[TBL] [Abstract][Full Text] [Related]
26. Paracellular and transcellular pathways facilitate insulin permeability in rat gut.
Lane ME; Corrigan OI
J Pharm Pharmacol; 2006 Feb; 58(2):271-5. PubMed ID: 16451757
[TBL] [Abstract][Full Text] [Related]
27. Multiple cleavage sites of cholecystokinin heptapeptide by "enkephalinase".
Durieux C; Charpentier B; Fellion E; Gacel G; Pelaprat D; Roques BP
Peptides; 1985; 6(3):495-501. PubMed ID: 3906590
[TBL] [Abstract][Full Text] [Related]
28. Reversed-phase liquid chromatography with ultraviolet detection for simultaneous quantitation of indinavir and propranolol from ex-vivo rat intestinal permeability studies.
Panchagnula R; Bansal T; Varma MV; Kaul CL
J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Jul; 806(2):277-82. PubMed ID: 15171939
[TBL] [Abstract][Full Text] [Related]
29. Asymmetric intestinal first-pass metabolism causes minimal oral bioavailability of midazolam in cynomolgus monkey.
Nishimura T; Amano N; Kubo Y; Ono M; Kato Y; Fujita H; Kimura Y; Tsuji A
Drug Metab Dispos; 2007 Aug; 35(8):1275-84. PubMed ID: 17470527
[TBL] [Abstract][Full Text] [Related]
30. Permeability dominates in vivo intestinal absorption of P-gp substrate with high solubility and high permeability.
Cao X; Yu LX; Barbaciru C; Landowski CP; Shin HC; Gibbs S; Miller HA; Amidon GL; Sun D
Mol Pharm; 2005; 2(4):329-40. PubMed ID: 16053336
[TBL] [Abstract][Full Text] [Related]
31. Amino acids in the rat intestinal lumen regulate their own absorption from a distant intestinal site.
Mourad FH; Barada KA; Khoury C; Hamdi T; Saadé NE; Nassar CF
Am J Physiol Gastrointest Liver Physiol; 2009 Aug; 297(2):G292-8. PubMed ID: 19541927
[TBL] [Abstract][Full Text] [Related]
32. An oral human drug absorption study to assess the impact of site of delivery on the bioavailability of bevirimat.
Connor A; Evans P; Doto J; Ellis C; Martin DE
J Clin Pharmacol; 2009 May; 49(5):606-12. PubMed ID: 19304891
[TBL] [Abstract][Full Text] [Related]
33. Conjugation of poorly absorptive drugs with mucoadhesive polymers for the improvement of oral absorption of drugs.
Sakuma S; Matsumoto T; Yamashita S; Wang Y; Lu ZR
J Control Release; 2007 Nov; 123(3):195-202. PubMed ID: 17888541
[TBL] [Abstract][Full Text] [Related]
34. Oral peptide delivery: improving the systemic availability of small peptides and enkephalin analogs.
Lee HJ; Amidon GL
NIDA Res Monogr; 1995; 154():86-106. PubMed ID: 8606751
[No Abstract] [Full Text] [Related]
35. [Methodologies for regulation of intestinal absorption of biologically active peptides].
Fujita T; Muranishi S
Nihon Rinsho; 1998 Mar; 56(3):589-94. PubMed ID: 9549341
[TBL] [Abstract][Full Text] [Related]
36. Permeability and absorption of leuprolide from various intestinal regions in rabbits and rats.
Zheng Y; Qiu Y; Lu MF; Hoffman D; Reiland TL
Int J Pharm; 1999 Aug; 185(1):83-92. PubMed ID: 10425368
[TBL] [Abstract][Full Text] [Related]
37. In situ and in vivo efficacy of peroral absorption enhancers in rats and correlation to in vitro mechanistic studies.
Sharma P; Varma MV; Chawla HP; Panchagnula R
Farmaco; 2005; 60(11-12):874-83. PubMed ID: 16243320
[TBL] [Abstract][Full Text] [Related]
38. Enhancing mechanism of Labrasol on intestinal membrane permeability of the hydrophilic drug gentamicin sulfate.
Koga K; Kusawake Y; Ito Y; Sugioka N; Shibata N; Takada K
Eur J Pharm Biopharm; 2006 Aug; 64(1):82-91. PubMed ID: 16750354
[TBL] [Abstract][Full Text] [Related]
39. Scaling of in vitro membrane permeability to predict P-glycoprotein-mediated drug absorption in vivo.
Shirasaka Y; Masaoka Y; Kataoka M; Sakuma S; Yamashita S
Drug Metab Dispos; 2008 May; 36(5):916-22. PubMed ID: 18276834
[TBL] [Abstract][Full Text] [Related]
40. The effect of different lipid based formulations on the oral absorption of lipophilic drugs: the ability of in vitro lipolysis and consecutive ex vivo intestinal permeability data to predict in vivo bioavailability in rats.
Dahan A; Hoffman A
Eur J Pharm Biopharm; 2007 Aug; 67(1):96-105. PubMed ID: 17329087
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
